Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Amortization - GoodwillEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares OutstandingWages, Salaries and Other
Ratios

Harvard Bioscience (HBIO) Accumulated Depreciation & Amortization (2016 - 2024)

Historic Accumulated Depreciation & Amortization for Harvard Bioscience (HBIO) over the last 16 years, with Q4 2024 value amounting to $15.8 million.

  • Harvard Bioscience's Accumulated Depreciation & Amortization rose 997.57% to $15.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $15.8 million, marking a year-over-year increase of 997.57%. This contributed to the annual value of $15.8 million for FY2024, which is 997.57% up from last year.
  • According to the latest figures from Q4 2024, Harvard Bioscience's Accumulated Depreciation & Amortization is $15.8 million, which was up 997.57% from $14.4 million recorded in Q4 2023.
  • Harvard Bioscience's Accumulated Depreciation & Amortization's 5-year high stood at $16.6 million during Q4 2020, with a 5-year trough of $14.4 million in Q4 2023.
  • Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $15.1 million (2020), whereas its average is $15.2 million.
  • Within the past 5 years, the most significant YoY rise in Harvard Bioscience's Accumulated Depreciation & Amortization was 1109.1% (2020), while the steepest drop was 1565.11% (2020).
  • Quarter analysis of 5 years shows Harvard Bioscience's Accumulated Depreciation & Amortization stood at $16.6 million in 2020, then decreased by 12.94% to $14.4 million in 2021, then rose by 2.75% to $14.8 million in 2022, then dropped by 3.11% to $14.4 million in 2023, then increased by 9.98% to $15.8 million in 2024.
  • Its last three reported values are $15.8 million in Q4 2024, $14.4 million for Q4 2023, and $14.8 million during Q4 2022.